Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 4, 2013, Pages 287.e1-287.e15

  Chaiworapongsa, Tinnakorn ^a,b,d   Romero, Roberto ^a,d   Korzeniewski, Steven J ^a,b   Kusanovic, Juan Pedro ^c   Soto, Eleazar ^a,b   Lam, Jennifer ^a,b   Dong, Zhong ^a   Than, Nandor G ^a,b   Yeo, Lami ^a,b   Hernandez Andrade, Edgar ^a,b   Conde Agudelo, Agustín ^a   Hassan, Sonia S ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

fetal death; placental growth factor (PlGF); small for gestational age (SGA); soluble endoglin (sEng); soluble vascular endothelial growth factor receptor 1 (sVEGFR 1)

Indexed keywords

ENDOGLIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PATIENT IDENTIFICATION; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; STILLBIRTH; THIRD TRIMESTER PREGNANCY;

EID: 84875424639     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.01.016     Document Type: Article

References (159)

1. R. Romero, C. Lockwood, E. Oyarzun, J.C. Hobbins Toxemia: new concepts in an old disease Semin Perinatol 12 1988 302 323
2. C.W. Redman, I.L. Sargent Latest advances in understanding preeclampsia Science 308 2005 1592 1594
3. C.J. Berg, W.M. Callaghan, C. Syverson, Z. Henderson Pregnancy-related mortality in the United States, 1998 to 2005 Obstet Gynecol 116 2010 1302 1309
4. J. Zhang, S. Meikle, A. Trumble Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States Hypertens Pregnancy 22 2003 203 212
5. I.A. Brosens Morphological changes in the utero-placental bed in pregnancy hypertension Clin Obstet Gynaecol 4 1977 573 593
6. J.J. Brosens, R. Pijnenborg, I.A. Brosens The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature Am J Obstet Gynecol 187 2002 1416 1423
7. R. Pijnenborg, J. Anthony, D.A. Davey Placental bed spiral arteries in the hypertensive disorders of pregnancy BJOG 98 1991 648 655
8. W.B. Robertson, I. Brosens, G. Dixon Maternal uterine vascular lesions in the hypertensive complications of pregnancy Perspect Nephrol Hypertens 5 1976 115 127
9. I. Brosens, R. Pijnenborg, L. Vercruysse, R. Romero The "Great Obstetrical Syndromes" are associated with disorders of deep placentation Am J Obstet Gynecol 204 2011 193 201
10. R. Romero, J.P. Kusanovic, T. Chaiworapongsa, S.S. Hassan Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae Best Pract Res Clin Obstet Gynaecol 25 2011 313 327
11. G.P. Sacks, K. Studena, K. Sargent, C.W. Redman Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis Am J Obstet Gynecol 179 1998 80 86
12. C.W. Redman, G.P. Sacks, I.L. Sargent Preeclampsia: an excessive maternal inflammatory response to pregnancy Am J Obstet Gynecol 180 1999 499 506
13. M.T. Gervasi, T. Chaiworapongsa, P. Pacora Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia Am J Obstet Gynecol 185 2001 792 797
14. S.A. Friedman, E. Schiff, J.J. Emeis, G.A. Dekker, B.M. Sibai Biochemical corroboration of endothelial involvement in severe preeclampsia Am J Obstet Gynecol 172 1995 202 203
15. F. Lyall, I.A. Greer The vascular endothelium in normal pregnancy and pre-eclampsia Rev Reprod 1 1996 107 116
16. J.M. Roberts, R.N. Taylor, A. Goldfien Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia Am J Hypertens 4 1991 700 708
17. J.M. Roberts Endothelial dysfunction in preeclampsia Semin Reprod Endocrinol 16 1998 5 15
18. R.N. Taylor, C.J. de Groot, Y.K. Cho, K.H. Lim Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia Semin Reprod Endocrinol 16 1998 17 31
19. T. Chaiworapongsa, R. Romero, J. Yoshimatsu Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia J Matern Fetal Neonatal Med 12 2002 19 27
20. L. Petrozella, M. Mahendroo, B. Timmons, S. Roberts, D. McIntire, J.M. Alexander Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period Am J Obstet Gynecol 207 2012 140 146
21. K. de Boer, J.W. ten Cate, A. Sturk, J.J. Borm, P.E. Treffers Enhanced thrombin generation in normal and hypertensive pregnancy Am J Obstet Gynecol 160 1989 95 100
22. T. Chaiworapongsa, J. Yoshimatsu, J. Espinoza Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia J Matern Fetal Neonatal Med 11 2002 362 367
23. Y. Cadroy, H. Grandjean, J. Pichon Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia BJOG 100 1993 416 420
24. J.R. Higgins, J.J. Walshe, M.R. Darling, L. Norris, J. Bonnar Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies Am J Obstet Gynecol 179 1998 520 526
25. M. Hayashi, T. Inoue, K. Hoshimoto, H. Negishi, T. Ohkura, N. Inaba Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia Eur J Haematol 69 2002 297 302
26. C.A. Hubel Oxidative stress in the pathogenesis of preeclampsia Proc Soc Exp Biol Med 222 1999 222 235
27. J.E. Vaughan, S.W. Walsh Oxidative stress reproduces placental abnormalities of preeclampsia Hypertens Pregnancy 21 2002 205 223
28. L. Myatt, W. Kossenjans, R. Sahay, A. Eis, D. Brockman Oxidative stress causes vascular dysfunction in the placenta J Matern Fetal Med 9 2000 79 82
29. X. Zhou, G.Y. Zhang, J. Wang, S.L. Lu, J. Cao, L.Z. Sun A novel bridge between oxidative stress and immunity: the interaction between hydrogen peroxide and human leukocyte antigen G in placental trophoblasts during preeclampsia Am J Obstet Gynecol 206 2012 447-16
30. D.S. Torry, H.S. Wang, T.H. Wang, M.R. Caudle, R.J. Torry Preeclampsia is associated with reduced serum levels of placenta growth factor Am J Obstet Gynecol 179 1998 1539 1544
31. S.C. Tidwell, H.N. Ho, W.H. Chiu, R.J. Torry, D.S. Torry Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia Am J Obstet Gynecol 184 2001 1267 1272
32. S.E. Maynard, J.Y. Min, J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
33. K. Koga, Y. Osuga, O. Yoshino Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 2003 2348 2351
34. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 188 2003 177 182
35. V. Tsatsaris, F. Goffin, C. Munaut Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 2003 5555 5563
36. T. Chaiworapongsa, R. Romero, J. Espinoza Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award Am J Obstet Gynecol 190 2004 1541 1547
37. S. Venkatesha, M. Toporsian, C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649
38. T.L. Weissgerber, J.M. Roberts, A. Jeyabalan Haptoglobin phenotype, angiogenic factors, and preeclampsia risk Am J Obstet Gynecol 206 2012 358
39. P. von Dadelszen, L.A. Magee, J.M. Roberts Subclassification of preeclampsia Hypertens Pregnancy 22 2003 143 148
40. R. Romero, J. Vizoso, M. Emamian Clinical significance of liver dysfunction in pregnancy-induced hypertension Am J Perinatol 5 1988 146 151
41. R. Romero, M. Mazor, C.J. Lockwood Clinical significance, prevalence, and natural history of thrombocytopenia in pregnancy-induced hypertension Am J Perinatol 6 1989 32 38
42. P.A. Long, D.A. Abell, N.A. Beischer Fetal growth retardation and pre-eclampsia BJOG 87 1980 13 18
43. G. Ogge, T. Chaiworapongsa, J.P. Kusanovic Evidence that placental lesions are more frequent in early-onset than in late-onset preeclampsia Reprod Sci 18 2011 124A
44. B.M. Sibai Preeclampsia as a cause of preterm and late preterm (near-term) births Semin Perinatol 30 2006 16 19
45. B. Sibai, G. Dekker, M. Kupferminc Pre-eclampsia Lancet 365 2005 785 799
46. K.L. Ales, M.E. Charlson Epidemiology of preeclampsia and eclampsia Am J Obstet Gynecol 165 1991 238
47. D.J. Tuffnell, D. Jankowicz, S.W. Lindow Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003 BJOG 112 2005 875 880
48. D.D. McIntire, K.J. Leveno Neonatal mortality and morbidity rates in late preterm births compared with births at term Obstet Gynecol 111 2008 35 41
49. J.M. Lubow, H.Y. How, M. Habli, R. Maxwell, B.M. Sibai Indications for delivery and short-term neonatal outcomes in late preterm as compared with term births Am J Obstet Gynecol 200 2009 e30 e33
50. C.V. Ananth, A.M. Vintzileos Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth Am J Obstet Gynecol 195 2006 1557 1563
51. L. Kenneth, D.R. Hall, S. Gebhardt, D. Grove Late onset preeclampsia is not an innocuous condition Hypertens Pregnancy 29 2010 262 270
52. S. Liu, K.S. Joseph, R.M. Liston Incidence, risk factors, and associated complications of eclampsia Obstet Gynecol 118 2011 987 994
53. L. Duley, A.M. Gulmezoglu, D.J. Henderson-Smart, D. Chou Magnesium sulphate and other anticonvulsants for women with pre-eclampsia Cochrane Database Syst Rev 2010 CD000025
54. J. Moodley Maternal deaths associated with hypertensive disorders of pregnancy: a population-based study Hypertens Pregnancy 23 2004 247 256
55. R. Romero Prenatal medicine: the child is the father of the man J Matern Fetal Neonatal Med 22 2009 636 639
56. R.C. Fretts Etiology and prevention of stillbirth Am J Obstet Gynecol 193 2005 1923 1935
57. J.F. Froen, J. Cacciatore, E.M. McClure Stillbirths: why they matter Lancet 377 2011 1353 1366
58. J.E. Lawn, M.Y. Yakoob, R.A. Haws, T. Soomro, G.L. Darmstadt, Z.A. Bhutta 3.2 million stillbirths: epidemiology and overview of the evidence review BMC Pregnancy Childbirth 9 suppl 1 2009 S2
59. Z.A. Bhutta, M.Y. Yakoob, J.E. Lawn Stillbirths: what difference can we make and at what cost? Lancet 377 2011 1523 1538
60. V. Flenady, P. Middleton, G.C. Smith Stillbirths: the way forward in high-income countries Lancet 377 2011 1703 1717
61. J.E. Lawn, H. Blencowe, R. Pattinson Stillbirths: Where? When? Why? How to make the data count? Lancet 377 2011 1448 1463
62. E.M. McClure, S. Saleem, O. Pasha, R.L. Goldenberg Stillbirth in developing countries: a review of causes, risk factors and prevention strategies J Matern Fetal Neonatal Med 22 2009 183 190
63. E.V. Menezes, M.Y. Yakoob, T. Soomro, R.A. Haws, G.L. Darmstadt, Z.A. Bhutta Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy BMC Pregnancy Childbirth 9 suppl 1 2009 S4
64. M.Y. Yakoob, J.E. Lawn, G.L. Darmstadt, Z.A. Bhutta Stillbirths: epidemiology, evidence, and priorities for action Semin Perinatol 34 2010 387 394
65. G.C. Smith Predicting antepartum stillbirth Clin Obstet Gynecol 53 2010 597 606
66. D. Hui, N. Okun, K. Murphy, J. Kingdom, E. Uleryk, P.S. Shah Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review J Obstet Gynaecol Can 34 2012 142 153
67. A. Reuvekamp, F.V. Velsing-Aarts, I.E. Poulina, J.J. Capello, A.J. Duits Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia BJOG 106 1999 1019 1022
68. A. Ahmed New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications Thromb Res 127 suppl 3 2011 S72 S75
69. A. Luttun, P. Carmeliet Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? J Clin Invest 111 2003 600 602
70. E. Bujold, R. Romero, T. Chaiworapongsa Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin J Matern Fetal Neonatal Med 18 2005 9 16
71. F. Crispi, C. Dominguez, E. Llurba, P. Martin-Gallan, L. Cabero, E. Gratacos Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction Am J Obstet Gynecol 195 2006 201 207
72. T. Chaiworapongsa, R. Romero, F. Gotsch Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age J Matern Fetal Neonatal Med 21 2008 41 52
73. T. Chaiworapongsa, R. Romero, A.L. Tarca A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia Am J Obstet Gynecol 202 2010 550-10
74. S.J. Benton, Y. Hu, F. Xie Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays Am J Obstet Gynecol 205 2011 469-8
75. V.D. Garovic The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension Hypertension 59 2012 555 557
76. S.K. Ghosh, S. Raheja, A. Tuli, C. Raghunandan, S. Agarwal Serum PLGF as a potential biomarker for predicting the onset of preeclampsia Arch Gynecol Obstet 285 2012 417 422
77. T. Chaiworapongsa, R. Romero, Z.A. Savasan Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia J Matern Fetal Neonatal Med 24 2011 1187 1207
78. H. Hagmann, R. Thadhani, T. Benzing, S.A. Karumanchi, H. Stepan The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia Clin Chem 58 2012 837 845
79. A. Molvarec, A. Szarka, S. Walentin, E. Szucs, B. Nagy, J. Rigo Jr Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia Hypertens Res 33 2010 892 898
80. S. Rana, C.E. Powe, S. Salahuddin Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia Circulation 125 2012 911 919
81. S. Verlohren, H. Stepan, R. Dechend Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia Clin Sci (Lond) 122 2012 43 52
82. A.C. Staff, K. Braekke, G.M. Johnsen, S.A. Karumanchi, N.K. Harsem Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia Am J Obstet Gynecol 197 2007 176
83. G.C. Smith, H. Wear The perinatal implications of angiogenic factors Curr Opin Obstet Gynecol 21 2009 111 116
84. S. Weed, J.A. Bastek, L. Anton, M.A. Elovitz, S. Parry, S.K. Srinivas Examining the correlation between placental and serum placenta growth factor in preeclampsia Am J Obstet Gynecol 207 2012 140 146
85. S.E. Maynard, S.A. Karumanchi Angiogenic factors and preeclampsia Semin Nephrol 31 2011 33 46
86. C. Lam, K.H. Lim, S.A. Karumanchi Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia Hypertension 46 2005 1077 1085
87. S.A. Karumanchi, S.E. Maynard, I.E. Stillman, F.H. Epstein, V.P. Sukhatme Preeclampsia: a renal perspective Kidney Int 67 2005 2101 2113
88. R.J. Levine, S.A. Karumanchi Circulating angiogenic factors in preeclampsia Clin Obstet Gynecol 48 2005 372 386
89. T. Chaiworapongsa, J. Espinoza, F. Gotsch The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation J Matern Fetal Neonatal Med 21 2008 25 40
90. F. Crispi, E. Llurba, C. Dominguez, P. Martin-Gallan, L. Cabero, E. Gratacos Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction Ultrasound Obstet Gynecol 31 2008 303 309
91. B.O. Asvold, L.J. Vatten, P.R. Romundstad, P.A. Jenum, S.A. Karumanchi, A. Eskild Angiogenic factors in maternal circulation and the risk of severe fetal growth restriction Am J Epidemiol 173 2011 630 639
92. V. Gourvas, E. Dalpa, A. Konstantinidou, N. Vrachnis, D.A. Spandidos, S. Sifakis Angiogenic factors in placentas from pregnancies complicated by fetal growth restriction [review] Mol Med Report 6 2012 23 27
93. J. Espinoza, T. Chaiworapongsa, R. Romero Unexplained fetal death: another anti-angiogenic state J Matern Fetal Neonatal Med 20 2007 495 507
94. T. Chaiworapongsa, R. Romero, J.P. Kusanovic Unexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluid J Matern Fetal Neonatal Med 23 2010 794 805
95. T. Chaiworapongsa, J.P. Kusanovic, Z.A. Savasan Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments J Matern Fetal Neonatal Med 23 2010 960 972
96. K. Bixel, M. Silasi, C.M. Zelop Placental origins of angiogenic dysfunction in mirror syndrome Hypertens Pregnancy 31 2012 211 217
97. J. Espinoza, R. Romero, J.K. Nien A role of the anti-angiogenic factor sVEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome) J Matern Fetal Neonatal Med 19 2006 607 613
98. D. Kanter, M.D. Lindheimer, E. Wang Angiogenic dysfunction in molar pregnancy Am J Obstet Gynecol 202 2010 184 185
99. K. Koga, Y. Osuga, T. Tajima Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole Fertil Steril 94 2010 305 308
100. J.P. Kusanovic, R. Romero, J. Espinoza Twin-to-twin transfusion syndrome: an antiangiogenic state? Am J Obstet Gynecol 198 2008 382 388
101. E. Llurba, G. Marsal, O. Sanchez Angiogenic and antiangiogenic factors before and after resolution of maternal mirror syndrome Ultrasound Obstet Gynecol 2011 Epub ahead of print
102. S. Rana, S. Venkatesha, M. DePaepe, E.K. Chien, M. Paglia, S.A. Karumanchi Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors Obstet Gynecol 109 2007 549 552
103. T. Chaiworapongsa, R. Romero, Y.M. Kim Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia J Matern Fetal Neonatal Med 17 2005 3 18
104. T.A. Moore Simas, S.L. Crawford, M.J. Solitro, S.C. Frost, B.A. Meyer, S.E. Maynard Angiogenic factors for the prediction of preeclampsia in high-risk women Am J Obstet Gynecol 197 2007 244 248
105. O. Erez, R. Romero, J. Espinoza The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age J Matern Fetal Neonatal Med 21 2008 279 287
106. R. Romero, J.K. Nien, J. Espinoza A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate J Matern Fetal Neonatal Med 21 2008 9 23
107. E.R. Unal, C.J. Robinson, D.D. Johnson, E.Y. Chang Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia Am J Obstet Gynecol 197 2007 211 214
108. M. Widmer, J. Villar, A. Benigni, A. Conde-Agudelo, S.A. Karumanchi, M. Lindheimer Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review Obstet Gynecol 109 2007 168 180
109. C.W. Park, J.S. Park, S.S. Shim, J.K. Jun, B.H. Yoon, R. Romero An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia Am J Obstet Gynecol 193 2005 984 989
110. R. Romero, T. Chaiworapongsa, O. Erez An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study J Matern Fetal Neonatal Med 23 2010 1384 1399
111. G.C. Smith, J.A. Crossley, D.A. Aitken Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth Obstet Gynecol 109 2007 1316 1324
112. M. Parra-Cordero, R. Rodrigo, P. Barja Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during the first trimester of pregnancy Ultrasound Obstet Gynecol 2012 Epub ahead of print
113. L.G. Di, M. Ceccarello, V. Cecotti First trimester maternal serum PIGF, free beta-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia Placenta 33 2012 495 501
114. L.C. Poon, R. Akolekar, R. Lachmann, J. Beta, K.H. Nicolaides Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks Ultrasound Obstet Gynecol 35 2010 662 670
115. A.C. Pedrosa, A. Matias Screening for pre-eclampsia: a systematic review of tests combining uterine artery Doppler with other markers J Perinat Med 39 2011 619 635
116. A.K. Wikstrom, A. Larsson, U.J. Eriksson, P. Nash, S. Norden-Lindeberg, M. Olovsson Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia Obstet Gynecol 109 2007 1368 1374
117. C.J. Robinson, D.D. Johnson, E.Y. Chang, D.M. Armstrong, W. Wang Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia Am J Obstet Gynecol 195 2006 255 259
118. R.J. Levine, S.E. Maynard, C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
119. J.P. Kusanovic, R. Romero, T. Chaiworapongsa A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia J Matern Fetal Neonatal Med 22 2009 1021 1038
120. R.J. Levine, C. Lam, C. Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005
121. A. Ohkuchi, C. Hirashima, S. Matsubara Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia Hypertens Res 30 2007 151 159
122. R.W. Powers, A. Jeyabalan, R.G. Clifton Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies PLoS One 5 2010 e13263
123. S.K. Srinivas, J. Larkin, M.D. Sammel The use of angiogenic factors in discriminating preeclampsia: are they ready for prime time? J Matern Fetal Neonatal Med 23 2010 1294 1300
124. C. Kleinrouweler, M. Wiegerinck, C. Ris-Stalpers Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis BJOG 119 2012 778 787
125. G.C. Smith Researching new methods of screening for adverse pregnancy outcome: lessons from pre-eclampsia PLoS Med 9 2012 e1001274
126. American College of Obstetricians and Gynecologists ACOG practice bulletin no. 33: diagnosis and management of preeclampsia and eclampsia Obstet Gynecol 99 2002 159 167
127. R.P. Gonzalez, R.M. Gomez, R.S. Castro [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000] Rev Med Chil 132 2004 1155 1165
128. M.F. MacDorman, S. Kirmeyer The challenge of fetal mortality NCHS Data Brief 16 2009 1 8
129. G. Albaiges, H. Missfelder-Lobos, C. Lees, M. Parra, K.H. Nicolaides One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation Obstet Gynecol 96 2000 559 564
130. C.K. Yu, O. Khouri, N. Onwudiwe, Y. Spiliopoulos, K.H. Nicolaides Fetal Medicine Foundation Second-Trimester Screening Group Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age Ultrasound Obstet Gynecol 31 2008 310 313
131. R. Koenker, G. Bassett Regression quantiles Econometrica 46 1978 36 50
132. E.W. Steyerberg, M.J. Eijkemans, F.E. Harrell Jr, J.D. Habbema Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets Stat Med 19 2000 1059 1079
133. F.E. Harrell Jr, K.L. Lee, D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
134. E.R. DeLong, D.M. DeLong, D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
135. R.W. Redline, D. Heller, S. Keating, J. Kingdom Placental diagnostic criteria and clinical correlation: a workshop report Placenta 26 suppl A 2005 S114 S117
136. E. Jauniaux, B. Gulbis, S. Tunkel, B. Ramsay, S. Campbell, S. Meuris Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies Prenat Diagn 16 1996 1129 1135
137. G.C. Smith, J.A. Crossley, D.A. Aitken First-trimester placentation and the risk of antepartum stillbirth JAMA 292 2004 2249 2254
138. K. Spencer, C.K. Yu, N.J. Cowans, C. Otigbah, K.H. Nicolaides Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler Prenat Diagn 25 2005 949 953
139. L. Dugoff, J.C. Hobbins, F.D. Malone Quad screen as a predictor of adverse pregnancy outcome Obstet Gynecol 106 2005 260 267
140. A.O. Odibo, H.M. Sehdev, D.M. Stamilio, G.A. Macones Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction Am J Perinatol 23 2006 363 367
141. A. Gagnon, R.D. Wilson, F. Audibert Obstetrical complications associated with abnormal maternal serum markers analytes J Obstet Gynaecol Can 30 2008 918 949
142. R.N. Olsen, D. Woelkers, R. Dunsmoor-Su, D.Y. Lacoursiere Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia Am J Obstet Gynecol 207 2012 228.e1 228.e7
143. A.T. Papageorghiou, C.K. Yu, R. Bindra, G. Pandis, K.H. Nicolaides Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation Ultrasound Obstet Gynecol 18 2001 441 449
144. A.T. Papageorghiou, K. Leslie Uterine artery Doppler in the prediction of adverse pregnancy outcome Curr Opin Obstet Gynecol 19 2007 103 109
145. G.C. Smith, C.K. Yu, A.T. Papageorghiou, A.M. Cacho, K.H. Nicolaides Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth Obstet Gynecol 109 2007 144 151
146. G.C. Smith, I. Shah, I.R. White, J.P. Pell, J.A. Crossley, R. Dobbie Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death BJOG 114 2007 705 714
147. M.F. MacDorman, S. Kirmeyer Fetal and perinatal mortality, United States, 2005 Natl Vital Stat Rep 57 2009 1 19
148. E. Bujold, S. Roberge, Y. Lacasse Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis Obstet Gynecol 116 2010 402 414
149. S. Roberge, P. Villa, K. Nicolaides Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis Fetal Diagn Ther 31 2012 141 146
150. J. Lee, R. Romero, Z. Dong Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies Histopathology 59 2011 928 938
151. T. Singh, K. Leslie, A. Bhide, F. D'Antonio, B. Thilaganathan Role of second-trimester uterine artery Doppler in assessing stillbirth risk Obstet Gynecol 119 2012 256 261
152. K. Spencer Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome Prenat Diagn 20 2000 652 656
153. Y. Yaron, M. Cherry, R.L. Kramer Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome Am J Obstet Gynecol 181 1999 968 974
154. N. Lepage, D. Chitayat, J. Kingdom, T. Huang Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies Am J Obstet Gynecol 188 2003 1354 1359
155. C.T. Banek, A.J. Bauer, A. Gingery, J.S. Gilbert Timing of ischemic insult alters fetal growth trajectory, maternal angiogenic balance and markers of renal oxidative stress in the pregnant rat Am J Physiol Regul Integr Comp Physiol 303 2012 R658 R664
156. L.W. Law, D.S. Sahota, L.W. Chan, M. Chen, T.K. Lau, T.Y. Leung Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women J Matern Fetal Neonatal Med 23 2010 1475 1480
157. K. Kumasawa, M. Ikawa, H. Kidoya et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model Proc Natl Acad Sci USA 108 2011 1451 1455
158. Z. Li, Y. Zhang, M.J. Ying Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia Hypertension 50 2007 686 692
159. R. Thadhani, T. Kisner, H. Hagmann Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia Circulation 124 2011 940 950